Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.77 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.77 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.59 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.59 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.53 |
| ▸ | PAM | P19021 | 1/20 | 0.52 |
| ▸ | CDC25B | P30305 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL23001581 | 0.98 | ALDH1A1 (0.74) | ALDH1A1MAPK1L3MBTL1TDP1SLC6A2 | |
| Hydrochloric Acid SCHEMBL29901825 | 0.98 | ALDH1A1 (0.74) | ALDH1A1MAPK1L3MBTL1TDP1SLC6A2 | |
| Acetic Acid SCHEMBL31078051 | 0.94 | ALDH1A1 (0.69) | ALDH1A1MAPK1L3MBTL1TDP1SLC6A2 | |
| Cyclopropane SCHEMBL29003079 | 0.94 | ALDH1A1 (0.69) | ALDH1A1MAPK1L3MBTL1TDP1SLC6A2 | |
| Alcohol SCHEMBL21245486 | 0.94 | ALDH1A1 (0.69) | ALDH1A1MAPK1L3MBTL1TDP1SLC6A2 | |
| Propionic Acid SCHEMBL31077917 | 0.91 | ALDH1A1 (0.65) | ALDH1A1MAPK1L3MBTL1TDP1SLC6A2 | |
| SCHEMBL361779 | 0.87 | ALDH1A1 (1.00) | ALDH1A1MAPK1L3MBTL1TDP1SLC6A2 | |
| SCHEMBL6784181 | 0.85 | ALDH1A1 (0.96) | ALDH1A1MAPK1L3MBTL1TDP1SLC6A2 | |
| Trifluoromethanesulfonic Acid SCHEMBL5035423 | 0.85 | ALDH1A1 (0.57) | ALDH1A1MAPK1L3MBTL1TDP1SLC6A2 | |
| SCHEMBL294341 | 0.84 | ALDH1A1 (0.73) | ALDH1A1MAPK1L3MBTL1TDP1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1033 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12503489-B2 | Method for producing antibody-drug conjugate | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2025-12-23 | — | — | US | claimed |
| EP-3677589-B1 | IMPROVED METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE | DAIICHI SANKYO CO LTD (JP) | 2025-11-26 | — | — | EP | claimed |
| WO-2025125052-A1 | METHOD FOR ACTIVATING A HETEROGENEOUS CATALYST IN THE PRESENCE OF A MULTIFUNCTIONAL ACID COMPOUND | IFP Energies Nouvelles (FR) | 2025-06-19 | — | — | WO | claimed |
| CN-119855060-B | PCB (printed circuit board) ink-jet printing pretreatment agent, preparation method thereof and PCB ink-jet printing method | 深圳市板明科技股份有限公司 | 2025-06-17 | — | — | CN | claimed |
| CN-119855060-A | PCB (printed circuit board) ink-jet printing pretreatment agent, preparation method thereof and PCB ink-jet printing method | 深圳市板明科技股份有限公司 | 2025-04-18 | — | — | CN | claimed |
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | claimed |
| CN-119350290-A | Method for preparing 1, 4-dioxane-2-ketone from ethylene carbonate | 青岛科技大学 | 2025-01-24 | — | — | CN | claimed |
| CN-119350291-A | Six-membered oxygen heterocyclic lactone, degradable polyether ester and preparation and degradation methods thereof | 青岛科技大学 | 2025-01-24 | — | — | CN | claimed |
| CN-117185976-B | Synthesis method of compound L635 | 深圳市灵兰生物医药科技有限公司 | 2024-12-31 | — | — | CN | claimed |
| US-20240376147-A1 | METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2024-11-14 | — | — | US | claimed |
| US-6140317-A | AS INHIBITORS OF PROTEIN KINASES AND HAVE ANTITUMOUR ACTIVITY | NOVARTIS AG (CH) | 2000-10-31 | — | — | US | claimed |
| EP-0888349-A1 | PYRROLOPYRIMIDINES AND PROCESSES FOR THEIR PREPARATION | Novartis AG (CH) | 1999-01-07 | — | — | EP | claimed |
| WO-1998043973-A1 | INTERMEDIATE PRODUCTS AND METHOD FOR THE PRODUCTION OF PYRIMIDINE DERIVATIVES | NOVARTIS AG (CH) | 1998-10-08 | — | — | WO | claimed |
| EP-0836605-A1 | PYRROLOPYRIMIDINES AND PROCESSES FOR THE PREPARATION THEREOF | Novartis AG (CH) | 1998-04-22 | — | — | EP | claimed |
| WO-1997027199-A1 | PYRROLOPYRIMIDINES AND PROCESSES FOR THEIR PREPARATION | NOVARTIS AG (CH) | 1997-07-31 | — | — | WO | claimed |
| WO-1997002266-A1 | PYRROLOPYRIMIDINES AND PROCESSES FOR THE PREPARATION THEREOF | NOVARTIS AG (CH) | 1997-01-23 | — | — | WO | claimed |
| US-5466701-A | Degenerative diseases | STERLING WINTHROP INC. (US) | 1995-11-14 | — | — | US | claimed |
| US-5378720-A | Treatment of rheumatoid arthritis, emphysema, pancreatitis | STERLING WINTHROP INC. (US) | 1995-01-03 | — | — | US | claimed |
| US-5336692-A | High-molecular-weight petrolatum, solvent and a compound both hydrophobic and hydrophilic; protective coatings for skin; moisturizers; spreadability; long-lasting | MEDICIS PHARMACEUTICAL CORPORATION (US) | 1994-08-09 | — | — | US | claimed |
| WO-1992000077-A1 | IMPROVED OINTMENT BASE AND METHOD OF USE | MEDICIS CORPORATION (US) | 1992-01-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12503489-B2 | Method for producing antibody-drug conjugate | UGT1A9, ALB, MRPL21 | ALDH1A1 257/4885MAPK1 2254/4885L3MBTL1 4302/4885 |
| US-20240376147-A1 | METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE | UGT1A9, ALB, MRPL21 | ALDH1A1 257/4885MAPK1 2254/4885L3MBTL1 4302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.